By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – MDxHealth today announced it will be sharing a $1.1 million grant with NovioGendix to develop tumor markers for bladder cancer.

The grant comes from Eurotrans-Bio, a European Commission initiative to foster cross-border R&D between companies and academia in the biotechnology space.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: swapping yeast genes with human orthologs to study conservation of function, and more.

Hong Kong is using DNA phenotyping to shame litterers.

A study appearing in Cell suggests some metastatic castration-resistant prostate cancer patients could benefit from PARP inhibitor therapy.

NIH's Francis Collins writes that scientific advances are poised to help populations all over the world, but more scientists are needed to keep the momentum.